Postmarketing safety surveillance for GSK’s AS01 <sub>E</sub> -adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study

20260 citationsJournal Articlegold Open Access

Authors

This protocol has been registered in the Heads of Medicines Agencies-European Medicines Agency Real World Data Catalogues (EUPAS1000000486).

Good health and well-being

Published in: BMJ Open

Volume 16, Issue 3, pp. e117236-e117236

Field-Weighted Citation Impact: 0.00